Skip to main content
VulnerabilityPublished

CVE-2026-7863: TUBITAK BILGEM Software Technologies Research Institute Pardus Software · OS Command Injection

Affects TUBITAK BILGEM Software Technologies Research Institute Pardus SoftwareSource CVE Database V5

0

Not known to be exploited · CVSS 8.4 High : upgrade to 1.0.5 soon.

Data as of 26 Oct 2026, 17:16 UTC

CVSS 3.1 base score
8.4High
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.9% chance of exploitation in 30 days – higher than 61% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
Patch
Available – fixed in 1.0.5
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 11 Sep 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.

What to do

Upgrade TUBITAK BILGEM Software Technologies Research Institute Pardus Software to 1.0.5.

Affected software

ProductAffectedFixed in
TUBITAK BILGEM Software Technologies Research InstitutePardus SoftwareAffected
  • <1.0.5
Fixed in
  • 1.0.5

AI-suggested

If you cannot patch yet, avoid using affected versions and apply standard OS command injection mitigations such as input validation and sanitization.

Description

Improper neutralization of special elements used in an OS command ('OS command injection') vulnerability in TUBITAK BILGEM Software Technologies Research Institute Pardus Software allows OS Command Injection. This issue affects Pardus Software: before 1.0.5.

References

Community reviews

Loading reviews…